Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 1
1994 4
1995 1
1996 3
1997 3
1998 2
1999 1
2000 4
2001 7
2002 3
2003 3
2004 5
2005 2
2006 6
2007 5
2008 3
2009 2
2010 1
2011 6
2012 7
2013 8
2014 1
2015 6
2016 3
2017 4
2018 9
2019 7
2020 15
2021 10
2022 15
2023 15
2024 9
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.
Baldacci S, Brea EJ, Facchinetti F, Li Z, Ngo K, Malhotra S, Booker MA, Tolstorukov MY, Chakravarti S, Hinchey C, Mahadevan NR, Lococo F, D'Agnelli S, Gnetti L, Campanini N, Leonetti A, Feng WW, Tsai JA, Hartley AV, Locquet MA, Fournel L, Alifano M, Mansuet-Lupo A, Saldanha A, Haller W, Zasadil LM, Zielinska M, Bui K, Tuladhar B, Lizotte PH, Ivanova EV, Sequist LV, Gokhale PC, Paweletz CP, Smith EL, Jänne PA, Barbie DA. Baldacci S, et al. Cancer Discov. 2025 Nov 3;15(11):2235-2250. doi: 10.1158/2159-8290.CD-24-1515. Cancer Discov. 2025. PMID: 40762432 Free PMC article.
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors.
Pecci F, Nakazawa S, Ricciuti B, Harada G, Lee JK, Alessi JV, Barrichello A, Vaz VR, Lamberti G, Di Federico A, Gandhi MM, Gazgalis D, Feng WW, Jiang J, Baldacci S, Locquet MA, Gottlieb FH, Chen MF, Lee E, Haradon D, Smokovich A, Voligny E, Nguyen T, Goel VK, Zimmerman Z, Atwal S, Wang X, Bahcall M, Heist RS, Iqbal S, Gandhi N, Elliott A, Vanderwalde AM, Ma PC, Halmos B, Liu SV, Che J, Schrock AB, Drilon A, Jänne PA, Awad MM. Pecci F, et al. Among authors: baldacci s. Cancer Discov. 2024 Aug 2;14(8):1440-1456. doi: 10.1158/2159-8290.CD-23-1217. Cancer Discov. 2024. PMID: 38564707 Free PMC article.
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.
Nakazawa S, Pecci F, Odintsov I, Gazgalis D, Gottlieb FH, Ricciuti B, Zullo L, Alessi JV, Di Federico A, Aldea M, Garbo E, Gandhi MM, Saini A, Feng WW, Jiang J, Baldacci S, Facchinetti F, Makarem M, Locquet MA, Haratani K, Haradon D, Besse B, Italiano A, Remon J, Lavaud P, Vasseur D, Planchard D, Sato Y, Watanabe Y, Owen S, Cortot AB, Mahran H, Forster MD, Niu J, Tomasini P, Leong SS, Tay K, Esteban E, Minchom A, Kizilbash SH, Cruz-Correa M, Yu KP, Zhang X, Chen P, Sangem M, Che J, Sholl LM, Jänne PA, Awad MM. Nakazawa S, et al. Among authors: baldacci s. Cancer Discov. 2025 Jun 3;15(6):1129-1140. doi: 10.1158/2159-8290.CD-24-1726. Cancer Discov. 2025. PMID: 40202082
Global Burden of Chronic Respiratory Diseases.
Viegi G, Maio S, Fasola S, Baldacci S. Viegi G, et al. Among authors: baldacci s. J Aerosol Med Pulm Drug Deliv. 2020 Aug;33(4):171-177. doi: 10.1089/jamp.2019.1576. Epub 2020 May 18. J Aerosol Med Pulm Drug Deliv. 2020. PMID: 32423274 Review.
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.
Brea EJ, Baldacci S, Savage N, Facchinetti F, Hinchey C, Chakravarti S, Mottram A, Ngo K, Vo H, Leeper BA, Tuladhar B, Ganapathy S, Ivanova EV, Saldanha A, Locquet MA, Salamah A, Holterhus M, Mesler EB, De Vizio M, Stornante C, Campisi M, Mahadevan NR, Thai TC, Haggerty TJ, Li Z, Nie C, Deng C, Wang X, Liu LL, Barbie TU, Gokhale PC, Paweletz CP, Ramasubramanian A, Jänne PA, Barbie DA, Smith EL. Brea EJ, et al. Among authors: baldacci s. Cancer Immunol Res. 2025 Nov 3;13(11):1749-1763. doi: 10.1158/2326-6066.CIR-25-0527. Cancer Immunol Res. 2025. PMID: 40920095 Free PMC article.
Outdoor air pollution and respiratory health.
Maio S, Sarno G, Tagliaferro S, Pirona F, Stanisci I, Baldacci S, Viegi G. Maio S, et al. Among authors: baldacci s. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):7-12. doi: 10.5588/ijtld.22.0249. Int J Tuberc Lung Dis. 2023. PMID: 36853127
Relationship of long-term air pollution exposure with chronic obstructive pulmonary disease: an Italian multicentre observational study.
Maio S, Fasola S, Marcon A, Angino A, Baldacci S, Bilò MB, Bono R, Fois AG, La Grutta S, Marchetti P, Sarno G, Squillacioti G, Stanisci I, Pirina P, Tagliaferro S, Verlato G, Villani S, Gariazzo C, Stafoggia M, Viegi G; BIGEPI group. Maio S, et al. Among authors: baldacci s. Occup Environ Med. 2025 Mar 4;82(1):21-27. doi: 10.1136/oemed-2024-109650. Occup Environ Med. 2025. PMID: 39961660
[BIGEPI project: environmental and health data].
Maio S, Gariazzo C, Stafoggia M, Ancona C, Bisceglia L, Caranci N, Cernigliaro A, Cesaroni G, Costa G, Marcon A, Massari S, Nobile F, Ranzi A, Renzi M, Scondotto S, Zengarini N, Verlato G, Viegi G; Gruppo Collaborativo BIGEPI. Maio S, et al. Epidemiol Prev. 2023 Nov-Dec;47(6):8-18. doi: 10.19191/EP23.6.S3.003. Epidemiol Prev. 2023. PMID: 38639296 Italian.
The multiple paths towards MET receptor addiction in cancer.
Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot AB, Copin MC, Tulasne D. Duplaquet L, et al. Among authors: baldacci s. Oncogene. 2018 Jun;37(24):3200-3215. doi: 10.1038/s41388-018-0185-4. Epub 2018 Mar 19. Oncogene. 2018. PMID: 29551767 Review.
169 results